MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on November 10, 2004; DOI: 10.1124/mol.104.006049


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.006049v1
67/2/541    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Welling, A.
Right arrow Articles by Wegener, J. W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Welling, A.
Right arrow Articles by Wegener, J. W


Received for publication August 11, 2004.
Revised November 9, 2004.
Accepted for publication November 9, 2004.

Inhibition of L-type Cav1.2 Ca2+ channels by LY294002 and Go6983

Andrea Welling 1, Franz Hofmann 1, Jorg W Wegener 1*

1 Technische Universitat Munchen

* Address correspondence to: E-mail: wegener{at}ipt.med.tu-muenchen.de

Abstract

Phosphatidylinositol 3-Kinase (PI3-K) is involved in physiological processes of cellular proliferation and inflammation, and, as postulated recently, in the regulation of L-type Ca2+ channels. The latter conclusion arose in part from the inhibitory action of the compound LY294002 which has been established as a selective PI3-K inhibitor (IC50 of 1.4 µM). Herein, we show, however, that LY294002 and, in addition, an inhibitor of protein kinase C (PKC), Go6983, act as direct Ca2+ channel inhibitors with IC50 values of about 20 and 10 µM, respectively. Since both drugs are commonly used at concentrations of about 10 µM or higher, the interpretation of such experiments is questionable with respect to a regulatory action of PI3-K or PKC on L-type Ca2+ channels.


Key words: Muscarinic cholinergic, Calcium (Votage-Gated Channels), Protein Kinase C, Func. analysis receptor/ion channel mutants, Knockout





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics